Johannes Lübke

12PUBLICATIONS
68CO-AUTHORS
Haematological tumoursGene and molecular therapyMedical mycologyClinical chemistry (incl. diagnostics)Allergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 28, 2026
Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER study.

Jason Gotlib, Andreas Reiter, Deepti H Radia

|Aug 09, 2025
Midostaurin in daily clinical practice of patients with advanced systemic mastocytosis.

Johannes Lübke, Nicole Naumann, Timo Brand

|Jan 15, 2025
Prognostic impact of expression of CD2, CD25, and/or CD30 in/on mast cells in systemic mastocytosis: a registry study of the European Competence Network on Mastocytosis.

Axel Rüfer, Henning Nilius, Olivier Hermine

|Apr 09, 2024
Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM.

Johannes Lübke, Alicia Schmid, Deborah Christen

|Mar 06, 2024
Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registries.

Johannes Lübke, Deborah Christen, Juliana Schwaab

|Feb 10, 2024
Poor Applicability of Currently Available Prognostic Scoring Systems for Prediction of Outcome in KIT D816V-Negative Advanced Systemic Mastocytosis.

Nicole Naumann, Martina Rudelius, Johannes Lübke

Pageof 2

Frequent Collaborators

6 joint publications

Jens Panse

5 joint publications

Peter Valent

4 joint publications

Nicholas C P Cross

4 joint publications

Andreas Reiter